{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:47:55Z","timestamp":1786996075237,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.prp.2022.154052","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T10:40:14Z","timestamp":1659177614000},"page":"154052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Hsa_circ_0102485 inhibits the growth of cancer cells by regulating the miR-188\u20133p\/ARID5B\/AR axis in prostate carcinoma"],"prefix":"10.1016","volume":"237","author":[{"given":"Zhenjie","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqian","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinglong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiansong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxia","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prp.2022.154052_bib1","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA: Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.prp.2022.154052_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"15","key":"10.1016\/j.prp.2022.154052_bib3","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1177\/15353702211012625","article-title":"Construction of enzalutamide-resistant cell model of prostate cancer and preliminary screening of potential drug-resistant genes","volume":"246","author":"Feng","year":"2021","journal-title":"Exp. Biol. Med. (Maywood, NJ)"},{"key":"10.1016\/j.prp.2022.154052_bib4","article-title":"CircRNA may not be \u201ccircular\u201d","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.prp.2022.154052_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.canlet.2021.02.004","article-title":"CircRNA in cancer: fundamental mechanism and clinical potential","volume":"505","author":"Chen","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2022.154052_bib6","article-title":"CircRNA circ_0092314 induces epithelial-mesenchymal transition of pancreatic cancer cells via elevating the expression of S100P by sponging miR-671","volume":"11","author":"Shen","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2022.154052_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.560506","article-title":"Analysis and validation of circRNA-miRNA network in regulating m(6)A RNA methylation modulators reveals CircMAP2K4\/miR-139-5p\/YTHDF1 axis involving the proliferation of hepatocellular carcinoma","volume":"11","author":"Chi","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2022.154052_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/cbr.2019.3490","article-title":"CircSMARCA5 facilitates the progression of prostate cancer through miR-432\/PDCD10 axis","volume":"36","author":"Dong","year":"2021","journal-title":"Cancer biotherapy Radiopharm."},{"key":"10.1016\/j.prp.2022.154052_bib9","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.2147\/OTT.S242482","article-title":"CircHIPK3 facilitates the G2\/M transition in prostate cancer cells by sponging miR-338-3p","volume":"13","author":"Liu","year":"2020","journal-title":"OncoTargets Ther."},{"issue":"13","key":"10.1016\/j.prp.2022.154052_bib10","doi-asserted-by":"crossref","first-page":"13255","DOI":"10.18632\/aging.103432","article-title":"Circular RNA circMBOAT2 promotes prostate cancer progression via a miR-1271-5p\/mTOR axis","volume":"12","author":"Shi","year":"2020","journal-title":"Aging"},{"issue":"16","key":"10.1016\/j.prp.2022.154052_bib11","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/pros.23699","article-title":"AT-rich interactive domain 5B regulates androgen receptor transcription in human prostate cancer cells","volume":"78","author":"Yamakawa","year":"2018","journal-title":"Prostate"},{"issue":"12","key":"10.1016\/j.prp.2022.154052_bib12","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1016\/j.febslet.2010.03.044","article-title":"Cytokinesis and cancer","volume":"584","author":"Sagona","year":"2010","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.prp.2022.154052_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41568-018-0084-6","article-title":"Cytokinesis defects and cancer","volume":"19","author":"Lens","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.prp.2022.154052_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017086","article-title":"A tumor-associated mutation of FYVE-CENT prevents its interaction with Beclin 1 and interferes with cytokinesis","volume":"6","author":"Sagona","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.prp.2022.154052_bib15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/ijms21165667","article-title":"MiR-93\/miR-375: diagnostic potential, aggressiveness correlation and common target genes in prostate cancer","volume":"21","author":"Ciszkowicz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2022.154052_bib16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12967-020-02644-x","article-title":"Systematic review and meta-analysis of the prognostic significance of microRNAs related to metastatic and EMT process among prostate cancer patients","volume":"19","author":"Parol","year":"2021","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.prp.2022.154052_bib17","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1158\/1078-0432.CCR-16-0497","article-title":"Genome-Wide miRNA analysis identifies miR-188-3p as a novel prognostic marker and molecular factor involved in colorectal carcinogenesis","volume":"23","author":"Pichler","year":"2017","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"3","key":"10.1016\/j.prp.2022.154052_bib18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/01616412.2020.1723298","article-title":"MiR-188-3p\/GPR26 modulation functions as a potential regulator in manipulating glioma cell properties","volume":"42","author":"Meng","year":"2020","journal-title":"Neurol. Res."},{"key":"10.1016\/j.prp.2022.154052_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ebiom.2019.05.053","article-title":"NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-\u03baB\/miR-188-3p pathways","volume":"44","author":"Meng","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.prp.2022.154052_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12935-019-0791-4","article-title":"TMED3 promotes cell proliferation and motility in breast cancer and is negatively modulated by miR-188-3p","volume":"19","author":"Pei","year":"2019","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.prp.2022.154052_bib21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2147\/OTT.S230795","article-title":"circGFRA1 enhances NSCLC progression by sponging miR-188-3p","volume":"13","author":"Yao","year":"2020","journal-title":"OncoTargets Ther."},{"issue":"4","key":"10.1016\/j.prp.2022.154052_bib22","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1021\/acs.molpharmaceut.8b00071","article-title":"MiroRNA-188 acts as tumor suppressor in non-small-cell lung cancer by targeting MAP3K3","volume":"15","author":"Zhao","year":"2018","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.prp.2022.154052_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13046-019-1055-9","article-title":"Long non-coding RNA LINC00346 promotes pancreatic cancer growth and gemcitabine resistance by sponging miR-188-3p to derepress BRD4 expression","volume":"38","author":"Shi","year":"2019","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"key":"10.1016\/j.prp.2022.154052_bib24","unstructured":"Gao F., Han J., Wang Y., Jia L., Luo W., Zeng Y.: Circ_0109291 Promotes the Cisplatin Resistance of Oral Squamous Cell Carcinoma by Sponging miR-188\u20133p to Increase ABCB1 Expression. Cancer biotherapy & radiopharmaceuticals 2020."},{"issue":"3","key":"10.1016\/j.prp.2022.154052_bib25","first-page":"95","article-title":"ARID proteins: a diverse family of DNA binding proteins implicated in the control of cell growth, differentiation, and development","volume":"13","author":"Wilsker","year":"2002","journal-title":"Cell Growth Differ.: Mol. Biol. J. Am. Assoc. Cancer Res."},{"issue":"8","key":"10.1016\/j.prp.2022.154052_bib26","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1101\/gr.168801","article-title":"Gene targeting of Desrt, a novel ARID class DNA-binding protein, causes growth retardation and abnormal development of reproductive organs","volume":"11","author":"Lahoud","year":"2001","journal-title":"Genome Res."},{"issue":"1","key":"10.1016\/j.prp.2022.154052_bib27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1158\/1078-0432.CCR-19-0190","article-title":"ARID5B influences antimetabolite drug sensitivity and prognosis of acute lymphoblastic leukemia","volume":"26","author":"Xu","year":"2020","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"11","key":"10.1016\/j.prp.2022.154052_bib28","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1089\/dna.2019.4926","article-title":"ARID5B genetic polymorphisms contribute to the susceptibility and prognosis of male acute promyelocytic leukemia","volume":"38","author":"Zhou","year":"2019","journal-title":"DNA Cell Biol."},{"issue":"7","key":"10.1016\/j.prp.2022.154052_bib29","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/JCMA.0000000000000038","article-title":"Genetic polymorphisms of ARID5B rs7089424 and rs10994982 are associated with B-lineage ALL susceptibility in Chinese pediatric population","volume":"82","author":"Tao","year":"2019","journal-title":"J. Chin. Med. Assoc.: JCMA"},{"key":"10.1016\/j.prp.2022.154052_bib30","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3389\/fgene.2020.00598","article-title":"The role of ARID5B in acute lymphoblastic leukemia and beyond","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Genet."},{"issue":"7","key":"10.1016\/j.prp.2022.154052_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159072","article-title":"Important role of FTO in the survival of rare panresistant triple-negative inflammatory breast cancer cells facing a severe metabolic challenge","volume":"11","author":"Singh","year":"2016","journal-title":"PloS One"},{"issue":"14","key":"10.1016\/j.prp.2022.154052_bib32","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/pros.23034","article-title":"Proteomics analysis of malignant and benign prostate tissue by 2D DIGE\/MS reveals new insights into proteins involved in prostate cancer","volume":"75","author":"Davalieva","year":"2015","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.prp.2022.154052_bib33","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbrc.2018.08.134","article-title":"Androgen receptor suppresses prostate cancer cell invasion via altering the miR-4496\/\u03b2-catenin signals","volume":"504","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"19","key":"10.1016\/j.prp.2022.154052_bib34","first-page":"7310","article-title":"Androgen receptor mediates the reduced tumor growth, enhanced androgen responsiveness, and selected target gene transactivation in a human prostate cancer cell line","volume":"61","author":"Cinar","year":"2001","journal-title":"Cancer Res."},{"issue":"34","key":"10.1016\/j.prp.2022.154052_bib35","doi-asserted-by":"crossref","first-page":"12188","DOI":"10.1073\/pnas.0804701105","article-title":"Targeting the stromal androgen receptor in primary prostate tumors at earlier stages","volume":"105","author":"Niu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"34","key":"10.1016\/j.prp.2022.154052_bib36","doi-asserted-by":"crossref","first-page":"12182","DOI":"10.1073\/pnas.0804700105","article-title":"Androgen receptor is a tumor suppressor and proliferator in prostate cancer","volume":"105","author":"Niu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.prp.2022.154052_bib37","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1210\/endo.141.9.7640","article-title":"Androgen receptor expression in prostate carcinoma cells suppresses alpha6beta4 integrin-mediated invasive phenotype","volume":"141","author":"Bonaccorsi","year":"2000","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.prp.2022.154052_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2605.2003.00375.x","article-title":"Androgen receptor and prostate cancer invasion","volume":"26","author":"Bonaccorsi","year":"2003","journal-title":"Int. J. Androl."},{"issue":"8\u20139","key":"10.1016\/j.prp.2022.154052_bib39","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.steroids.2004.05.011","article-title":"The androgen receptor associates with the epidermal growth factor receptor in androgen-sensitive prostate cancer cells","volume":"69","author":"Bonaccorsi","year":"2004","journal-title":"Steroids"},{"issue":"1\u20132","key":"10.1016\/j.prp.2022.154052_bib40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.mce.2005.11.006","article-title":"The androgen receptor and prostate cancer invasion","volume":"246","author":"Bonaccorsi","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.prp.2022.154052_bib41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.canlet.2015.08.001","article-title":"Androgen receptor inhibits epithelial-mesenchymal transition, migration, and invasion of PC-3 prostate cancer cells","volume":"369","author":"Huo","year":"2015","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.prp.2022.154052_bib42","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/pros.22676","article-title":"Androgen receptor enhances entosis, a non-apoptotic cell death, through modulation of Rho\/ROCK pathway in prostate cancer cells","volume":"73","author":"Wen","year":"2013","journal-title":"Prostate"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822002965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822002965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:54:51Z","timestamp":1759733691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033822002965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":42,"alternative-id":["S0344033822002965"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2022.154052","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hsa_circ_0102485 inhibits the growth of cancer cells by regulating the miR-188\u20133p\/ARID5B\/AR axis in prostate carcinoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2022.154052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154052"}}